CHARLIE KANO: Open Payments
NPI 1003927567 · MERCED, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,163 in 60 payments from 21 companies in 2025. Trend: 2023 $1,135 · 2024 $1,000 · 2025 $1,163
Food & beverage: $1,163
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $155 |
| GlaxoSmithKline, LLC. | 10 | $141 |
| Abbott Laboratories | 4 | $92 |
| Exact Sciences Corporation | 3 | $82 |
| AstraZeneca Pharmaceuticals LP | 4 | $73 |
| ABBVIE INC. | 3 | $72 |
| Axsome Therapeutics, Inc. | 3 | $67 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $58 |
| SANOFI PASTEUR INC. | 2 | $56 |
| Amgen Inc. | 3 | $53 |
Products named: FREESTYLE LIBRE 3, Cologuard Collection Kit, Auvelity, SHINGRIX, Kerendia, BEYFORTUS, Senza, Ozempic.
Industry payments across CA — which companies pay providers there.
